Main > PNEUMOLOGY > Steroids. > Mometasone Furoate. > Patent. > Claims > Claim 1: Nebulizer Suspension: > Mometasone Furoate Monohydrate > (MFM); Water; NonIonic Surfactant; > 0.2-2% NaCl & Optionally pH Buffer > Claim 2: (MFM): 50 micro.gr-5 mg/ml > Claim 3: PolySorbate Surfactant. > Claim 4: PolySorbate 80. Claim 5: > Poloxamer Surfactant. Claim 6: > Surfactant=50 micro.gr-1 mg/ml > Claim 8: Airway Disorders Treat.: > Adm. by Nebulization to Surfaces > of Airway Suspension (Cl. 1). > Claim 9: pH Buffer. Claim 10: > Citric Acid-Citrate Buffer. Claims > 11,12,13: pH=3-7; 3-6 & 4-5 resp. > Claims 14,15: Particle Size<5 & 2 > .mu.m. resp. Claim 16: > Nebulizer Suspension Mfg Process > a) Mixing All Ingredients & b) > Subject Mixt. Particle Size Redn. > by UltraSonication or Jet Milling > Patent Assignee

---

Patent Assignee's products
USA. S